CKD results in impaired GHR and GH signaling characterized by an altered GH-induced hepatic, as well as growth plate cartilage IGF-1 synthesis, due to a reduced expression of the GHR and/or a postreceptor signaling defect [156–158]. The gene discussed is IGF1; the disease is chronic kidney disease.